Report #2896704

Received May 15, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Recovered
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (NO BRAND NAME)	UNKNOWN MANUFACTURER	1	UNK	—

Symptoms (1)

Headache

Symptom narrative

Bad headache; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of headache in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced headache (Verbatim: Bad headache). The outcome of the headache was resolved (duration 1 month). It was unknown if the reporter considered the headache to be related to Shingles vaccine. It was unknown if the company considered the headache to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 07-MAY-2026 This case was reported by a patient via interactive digital media. The patient had bad headache for one month after 1st vaccine and was hard to go back for 2nd dose in July.